US-listed healthcare planning stocks led the decline, with UnitedHealth Group falling nearly 17%, Harmena Group falling over 16%, and Westlife Healthcare falling nearly 10%; this followed a US proposal to slightly increase the reimbursement rates for health insurance companies.